Concepedia

Godwin Kumi

GK

6

Publications

252

Citations

6

H-Index

2003

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Miami University

Lexicon Pharmaceuticals (United States)

Godwin Kumi is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and organic chemistry.

Top concepts

Publications per year

2003–2021

6

Publications

6

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor

Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 75 citations · Full text

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan, Godwin Kumi, Christopher W. Allard et al. · ACS Medicinal Chemistry Letters · 2021 · 51 citations · Full text

Total Synthesis of (<i>S</i>)-(−)-(<i>E</i>)-15,16-Dihydrominquartynoic Acid: A Highly Potent Anticancer Agent

Benjamin W. Gung, Godwin Kumi · The Journal of Organic Chemistry · 2004 · 40 citations

Remarkable Reactivity Difference in Oxygen-Substituted versus Non-Oxygen-Substituted Bromoalkynes in Cu(I)-Catalyzed Cross-Coupling Reactions:  Total Synthesis of (−)-<i>S</i>-18-Hydroxyminquartynoic Acid

Benjamin W. Gung, Godwin Kumi · The Journal of Organic Chemistry · 2003 · 29 citations

, , +15

Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88

Carolyn D. Dzierba, Yingzhi Bi, Bireshwar Dasgupta et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 29 citations · Full text

, , +7

Rows per page

1–5 of 6